Kevin Lobo, a director at GE HealthCare Technologies Inc. (NASDAQ:GEHC), recently purchased shares of common stock. The transaction, totaling $641,800, occurred on May 22, 2026.
Mr. Lobo acquired 10,000 shares at $64.18 per share. Following this direct purchase, he now directly holds 14,363 shares in the company.
The purchase comes as GEHC shares trade near their 52-week low, down 21.7% year-to-date. According to Bond.az analysis, the stock appears undervalued at current levels, with the company maintaining profitability over the last twelve months. The healthcare equipment company, valued at $29.2 billion, trades at a P/E ratio of 15.51.
In other recent news, GE HealthCare reported Q1 2026 revenues of $5.13 billion, showing 2.9% organic growth year-over-year, beating Oppenheimer's estimate of $4.96 billion. However, adjusted EPS of $0.99 fell short of estimates of $1.05. UBS upgraded GEHC to Neutral from Sell but lowered the price target to $69. Goldman Sachs downgraded to Neutral from Buy, reducing the target to $65 due to rising input costs.
GE HealthCare also announced advancements in MRI systems. The company elected eight directors and approved executive pay. Oppenheimer lowered its target to $85 from $89, maintaining an Outperform rating.
